Overall rank by patents
#32,840
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, active 2018–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA).
The verdict
Preventice holds 8 US patents across 8 technology areas, rank #32,840 of 50,000 tracked assignees.
Preventice Technologies, Inc. has been granted 8 US utility patents between 2018 and 2022, placing Preventice Technologies, Inc. at rank #32,840 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.0 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a US Corporation, Preventice Technologies, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Preventice sits between Precision Optical Transceivers Inc. (8 patents, rank #32,836) and PRO Medicare S.r.l. (8 patents, rank #32,844) - the closest US assignees by grant volume. The composite Innovation Score of 29.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 4 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Preventice Technologies, Inc.'s 18.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Preventice Technologies, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
PRECISION OPTICAL TRANSCEIVERS INC.
8 patents
PRESSTEK, LLC.
8 patents
PRESSURE BIOSCIENCES, INC.
8 patents
PRESYS. Co., Ltd.
8 patents
PRIMALOFT, INC.
8 patents
PRIMARY ARMS, LLC
8 patents
PRIME FOCUS TECHNOLOGIES LIMITED
8 patents
PRO MEDICARE S.R.L.
8 patents
PREVENTICE TECHNOLOGIES, INC.
8 patents
What this shows Preventice holds 8 patents at rank #32,840, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,840 in granted patent volume.
Other assignees with the most granted patents in Preventice's primary technology class.
Preventice's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
30 Top 68% higher than 32% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 25.0% |
| 2019 | 2 | 25.0% |
| 2021 | 3 | 37.5% |
| 2022 | 1 | 12.5% |
Top 8 of 8 technology areas
Overall rank by patents
#32,840
Across all tracked assignees
29.7 out of 100
How to use this portfolio
Preventice's 8 grants land it in the top 68% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.